Additional file 1 of BRIP1, RAD51C, and RAD51D mutations are associated with high susceptibility to ovarian cancer: mutation prevalence and precise risk estimates based on a pooled analysis of ~30,000 cases

Additional file 1: Figure S1. The flow diagram indicating the strategy and criteria used for the selection of articles for the analysis. Table S1. Characteristics of the studies eligible for meta-analysis. Table S2. The list of BRIP1 mutations identified in patients with OC, with their prevalence in OC patients and population controls and associated mutation-specific OC risk. Table S3. The list of RAD51C mutations identified in patients with OC, with their prevalence in OC patients and population controls and associated mutation-specific OC risk. Table S4. The list of RAD51D mutations identified in patients with OC, with their prevalence in OC patients and population controls and associated mutation-specific OC risk. Table S5. The list of BRIP1, RAD51C, and RAD51D large mutations reported in studies selected for analysis.